Antibodies specific for CD70 and their uses
MYPI2025003778A0Undetermined Publication Date: 2019-08-01PFIZER INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025003778
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2018-03-12
- Filing Date
- 2019-01-31
- Publication Date
- 2019-08-01
Abstract
The present invention provides antibodies that specifically bind to CD70 (Cluster of Differentiation 70). The invention further provides bispecific antibodies that bind to CD70 and another antigen (e.g., CD3). The invention further relates to antibody encoding nucleic acids, and methods of obtaining such antibodies (monospecific and bispecific). The invention further relates to therapeutic methods for use of these antibodies for the treatment of CD70-mediated pathologies, including cancer.
Need to check novelty before this filing date? Find Prior Art
